New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States

Oct.11.2022
New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States
The latest study on youth vaping in the US shows little progress in preventing teens from using e-cigarettes.

A new study conducted by the US government on the use of e-cigarettes among youth has shown little progress in keeping teenagers away from vaping. The survey, which was released on Thursday, suggests that more high school students are using e-cigarettes, with 14% of them reporting recent use compared to 11% in the previous year.


However, experts warn that changes in the survey make comparisons difficult: this year, there is a much higher proportion of participants surveyed in schools, and there are often more reports of e-cigarette use in schools than at home. "Assessing trends (in e-cigarette use) since the outbreak of the pandemic remains difficult," said Alyssa Harlow, a researcher at the University of Southern California who studies adolescent e-cigarette use.


Although there are still many young people using e-cigarettes, they don't seem to be as popular as before. In 2019, 28% of high school students reported having recently used e-cigarettes. For educators, e-cigarettes remain a major issue.


Interestingly, the 2021-22 academic year is worse than pre-pandemic times, according to Mike Rinaldi, the principal of Westhill High School in Connecticut. He notes that it is the first year for many students returning from remote learning during the pandemic and speculates that some may have turned to e-cigarettes to cope with pandemic-related mental health issues or stress. Matt Forker, principal of Stamford High School, says that kids vaping in school bathrooms and stairwells remains a "persistent challenge".


Researchers from the Centers for Disease Control and Prevention authored a new study based on an online survey conducted from January 18th to May 31st of approximately 28,000 American high school students. The study inquired about the use of electronic cigarettes and other vaping devices in the past 30 days. In addition to 14% of high schoolers reporting recent use of e-cigarettes, around 3% of middle schoolers reported having tried them. Among those who used e-cigarettes, approximately 28% reported daily use. Nearly 85% of young people using e-cigarettes used flavored products, with Puff Bar and Vuse being the most popular brands followed by Hyde and Smok.


After months of pressure from congressional members and parents, the US Food and Drug Administration (FDA) took action against the manufacturers of Puff Bar and Hyde on Thursday. The agency sent a warning letter to Puff Bar manufacturer, EVO Brands, stating that the company had not obtained permission to sell their products in the US and that they were being illegally sold. Only a few e-cigarette companies have received FDA approval, which is only granted to products that are beneficial to the health of adult smokers.


The agency also stated that following the denial of their FDA authorization application, they have instructed Magellan Technology, the manufacturer of Hyde, to withdraw their product from the market.


The FDA has been working to regulate the extensive e-cigarette industry, which includes both established and start-up companies. Regulatory agencies have faced criticism from Congress and anti-e-cigarette advocates as they have missed multiple deadlines and have been unable to make decisions on compliance applications for millions of e-cigarette products submitted by companies.


In the past three years, federal and state laws and regulations have increased the purchasing age for tobacco and e-cigarette products, and have banned almost all small e-cigarette flavors that are popular among teenagers.


Some children may have also been scared away by the outbreak of illnesses and deaths related to e-cigarettes in 2019 - most of whom were associated with additives in black market e-liquids containing THC, a chemical that can produce a marijuana-like high when inhaled.


A leader of an advocacy organization has stated that their efforts to combat youth vaping have not been progressing well. These figures "may not reflect the larger reality of youth e-cigarette use that we hear about every day from parents, teachers, pediatricians, and prevention experts who are dealing with this urgent and ongoing youth public health crisis," said the organization, which is made up of parents opposed to vaping, in a statement.


Earlier this summer, the U.S. Food and Drug Administration (FDA) attempted to ban products from leading e-cigarette manufacturer Juul due to concerns about potential health risks. However, after a court challenge, the effort was forced to be put on hold. In a survey conducted this year, approximately one-fifth of teenage e-cigarette users reported using Juul recently, although it is no longer the most popular brand. This is a significant shift from 2019 when over half of young people's most commonly used e-cigarette was Juul.


On the contrary, many young people have turned to electronic cigarettes that offer laboratory-manufactured nicotine, including Puff Bar, which is a loophole in the FDA supervision that was shut down by Congress this year. Despite obtaining new authorization for these products, the FDA missed the mid-July deadline to make decisions on most products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is intended solely for industry exchange and research.


Due to limitations in translation abilities, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and positions.


The compilation of information is subject to the ownership of the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
BAT’s Product Strategy Reset: A Structural Analysis of Its Post-FY2025 Competitive Architecture
BAT’s Product Strategy Reset: A Structural Analysis of Its Post-FY2025 Competitive Architecture
Drawing on BAT’s FY2025 results and earnings call, 2Firsts finds the company shifting from category expansion to competitive entrenchment across Vapour, Modern Oral, Heated Products and Combustibles. The strategy centers on connected devices, geographic customization and portfolio tiering. While structurally coherent, financial returns depend on consistent regulatory enforcement against illicit competitors, making policy execution a key variable for 2026 performance.
Feb.12
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
Japan Tobacco Launches Limited-Edition “Purple Dusk” Colorway for Ploom AURA, Priced at JPY 2,980
Japan Tobacco Launches Limited-Edition “Purple Dusk” Colorway for Ploom AURA, Priced at JPY 2,980
Japan Tobacco has launched the fourth installment of its limited-color series for the Ploom AURA heated-tobacco device, unveiling “Purple Dusk” . Priced at JPY 2,980 (about USD 18.7, tax included), it goes on limited early sale via official channels from Jan 13, before rolling out to convenience stores and other retail outlets across Japan from Jan 20.
Jan.13 by 2FIRSTS.ai
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.
Feb.12
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03